ArticleZeitschrift fur Rheumatologie2023

Relative effectiveness and safety of interleukin-6 and Janus kinase inhibitors versus adalimumab in patients with rheumatoid arthritis: a network meta-analysis.

Young Ho Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.